Angiotensin I and II in the assessment of baroreceptor function in fetal and neonatal sheep. 1986

G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark

In fetal and neonatal sheep intravenous injections of angiotensin I, angiotensin II and noradrenaline each increased mean blood pressure and decreased heart rate in a dose-dependent manner. Blood pressure responses to given doses of angiotensin I and II were larger in neonatal than fetal animals while the reverse was true for noradrenaline. In both sheep groups angiotensin II was more pressor than angiotensin I. Baroreceptor function was assessed by correlating blood pressure response to angiotensin II with corresponding changes in either heart rate or heart period. A more sensitive baroreceptor reflex was found in the fetal group in that a given blood pressure response resulted in a significantly larger bradycardia and the calculated gain of the reflex was higher. In those fetuses subjected to either bilateral vagotomy or cervical cord transection pressor responses to both angiotensin II and noradrenaline were enhanced but a significant change was only seen in the cervical cord transection fetuses. Heart rate responses to these drugs were essentially unchanged in the cervical cord transected fetuses while in vagotomized fetuses the bradycardia with each drug was replaced by a tachycardia. It is concluded that the baroreflex is more active in the fetus than the neonate and is mediated by autonomic effector mechanisms similar to those found in the adult.

UI MeSH Term Description Entries
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011311 Pressoreceptors Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls. Baroreceptors,Receptors, Stretch, Arterial,Receptors, Stretch, Vascular,Stretch Receptors, Arterial,Stretch Receptors, Vascular,Arterial Stretch Receptor,Arterial Stretch Receptors,Baroreceptor,Pressoreceptor,Receptor, Arterial Stretch,Receptor, Vascular Stretch,Receptors, Arterial Stretch,Receptors, Vascular Stretch,Stretch Receptor, Arterial,Stretch Receptor, Vascular,Vascular Stretch Receptor,Vascular Stretch Receptors
D012018 Reflex An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000803 Angiotensin I A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000809 Angiotensins Oligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized. Angiotensin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
January 1978, Clinical and experimental pharmacology & physiology,
G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
August 1997, The American journal of physiology,
G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
September 1989, Hypertension (Dallas, Tex. : 1979),
G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
October 1988, Cell biochemistry and function,
G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
January 1976, Birth defects original article series,
G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
December 2001, American journal of physiology. Regulatory, integrative and comparative physiology,
G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
March 1974, The American journal of physiology,
G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
January 2013, Journal of diabetes & metabolism,
G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
January 1981, Hypertension (Dallas, Tex. : 1979),
G C Scroop, and J D Marker, and B Stankewytsch-Janusch, and R F Seamark
December 1970, Computers and biomedical research, an international journal,
Copied contents to your clipboard!